Aradhana Goel

Aradhana Goel serves as Adjunct Professor for User Research for Digital and Physical Products (course 49-605) at Carnegie Mellon University's Integrated Innovation Institute. With over 25 years of leadership experience, she previously held roles as Head of Product Design & Behavior Science for Bayer Pharmaceuticals' Digital Health Portfolio, focusing on Cardiovascular & Women's Health solutions, and contributed to major transformations at Capital One, Sunrun, and IDEO.

Education:

• Master of Science, Design and Digital Technology - Massachusetts Institute of Technology, Cambridge, US
• Master, Urban Design - School of Planning and Architecture, New Delhi, India
• Diploma in Architecture - Sushant School of Art & Architecture, Gurgaon, India

Research Focus: Goel's work bridges behavior science and product innovation, emphasizing human-centered approaches to complex systems. Her expertise spans Product Strategy, New Product Development, and Behavior Change Design with applications in healthcare, financial services, and sustainable energy. She champions data-driven cultures while maintaining deep empathy for user needs through narrative techniques and systems-level thinking.

Publication Trends: Her scholarly output reveals an evolutionary trajectory from foundational work in user empathy methods (2003) and public information systems (2004) toward contemporary AI-driven healthcare solutions (2021), consistently applying behavioral insights to solve real-world problems across diverse domains.

Awards:

• IDEA Silver 2012 for Redbox Redesign (Industrial Designers Society of America)

Professional Impact: Goel has built high-performing cross-functional teams across pharmaceutical, banking, and renewable energy sectors while co-founding IDEO's India office. Her philosophy emphasizes proactive life shaping through strategic choices, reflected in her career transitions from architecture to digital health leadership. She actively shares insights through industry speaking engagements on Product & Design Innovation.